
Robert S. Cabral
Examiner (ID: 17715, Phone: (571)270-3769 , Office: P/1618 )
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1614, 1618 |
| Total Applications | 983 |
| Issued Applications | 563 |
| Pending Applications | 85 |
| Abandoned Applications | 347 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18091177
[patent_doc_number] => 20220409518
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => EMU Oil In Combination With Other Active Ingredients For Treating Skin Imperfections
[patent_app_type] => utility
[patent_app_number] => 17/895719
[patent_app_country] => US
[patent_app_date] => 2022-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6343
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17895719
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/895719 | EMU Oil In Combination With Other Active Ingredients For Treating Skin Imperfections | Aug 24, 2022 | Pending |
Array
(
[id] => 18483670
[patent_doc_number] => 20230210971
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => EDIBLE PLANT EXOSOME-LIKE NANOVECTORS FOR VACCINATION
[patent_app_type] => utility
[patent_app_number] => 17/889715
[patent_app_country] => US
[patent_app_date] => 2022-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12691
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17889715
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/889715 | EDIBLE PLANT EXOSOME-LIKE NANOVECTORS FOR VACCINATION | Aug 16, 2022 | Pending |
Array
(
[id] => 18389962
[patent_doc_number] => 20230158180
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => MULTIMODAL SILICA-BASED NANOPARTICLES
[patent_app_type] => utility
[patent_app_number] => 17/857413
[patent_app_country] => US
[patent_app_date] => 2022-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44924
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17857413
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/857413 | Multimodal silica-based nanoparticles | Jul 4, 2022 | Issued |
Array
(
[id] => 19209604
[patent_doc_number] => 11998642
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-04
[patent_title] => Multisomes: encapsulated droplet networks
[patent_app_type] => utility
[patent_app_number] => 17/853000
[patent_app_country] => US
[patent_app_date] => 2022-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 16
[patent_no_of_words] => 29459
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 174
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17853000
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/853000 | Multisomes: encapsulated droplet networks | Jun 28, 2022 | Issued |
Array
(
[id] => 19503833
[patent_doc_number] => 12115231
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-15
[patent_title] => Ultrasmall nanoparticles and methods of making and using same
[patent_app_type] => utility
[patent_app_number] => 17/852242
[patent_app_country] => US
[patent_app_date] => 2022-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 17
[patent_no_of_words] => 21012
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17852242
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/852242 | Ultrasmall nanoparticles and methods of making and using same | Jun 27, 2022 | Issued |
Array
(
[id] => 20239606
[patent_doc_number] => 12419910
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-23
[patent_title] => Acetic acid and hypochlorous acid compositions for treatment of skin trauma
[patent_app_type] => utility
[patent_app_number] => 17/842100
[patent_app_country] => US
[patent_app_date] => 2022-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 21
[patent_no_of_words] => 9967
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17842100
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/842100 | Acetic acid and hypochlorous acid compositions for treatment of skin trauma | Jun 15, 2022 | Issued |
Array
(
[id] => 20644758
[patent_doc_number] => 12599683
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-04-14
[patent_title] => Mapping nanoparticles
[patent_app_type] => utility
[patent_app_number] => 18/289215
[patent_app_country] => US
[patent_app_date] => 2022-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 13
[patent_no_of_words] => 12300
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 242
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18289215
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/289215 | Mapping nanoparticles | May 11, 2022 | Issued |
Array
(
[id] => 20401309
[patent_doc_number] => 12491269
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-09
[patent_title] => Radioactive yttrium phosphate suspension and method of preparing the same
[patent_app_type] => utility
[patent_app_number] => 17/740549
[patent_app_country] => US
[patent_app_date] => 2022-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 0
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17740549
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/740549 | Radioactive yttrium phosphate suspension and method of preparing the same | May 9, 2022 | Issued |
Array
(
[id] => 18180479
[patent_doc_number] => 20230041208
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => M13 PHAGE BASED GENE THERAPY PLATFORM
[patent_app_type] => utility
[patent_app_number] => 17/738647
[patent_app_country] => US
[patent_app_date] => 2022-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51443
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17738647
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/738647 | M13 phage based gene therapy platform | May 5, 2022 | Issued |
Array
(
[id] => 17944442
[patent_doc_number] => 20220331459
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => Distributing Microparticles
[patent_app_type] => utility
[patent_app_number] => 17/736435
[patent_app_country] => US
[patent_app_date] => 2022-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8837
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17736435
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/736435 | Distributing Microparticles | May 3, 2022 | Pending |
Array
(
[id] => 20592467
[patent_doc_number] => 12576163
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-17
[patent_title] => Fluorescent contrast agent with targeting function, and preparation method and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/661305
[patent_app_country] => US
[patent_app_date] => 2022-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 27
[patent_no_of_words] => 2452
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17661305
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/661305 | Fluorescent contrast agent with targeting function, and preparation method and use thereof | Apr 28, 2022 | Issued |
Array
(
[id] => 19279924
[patent_doc_number] => 20240216396
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-04
[patent_title] => NEUROACTIVE STEROID FOR USE IN TREATING MAJOR DEPRESSIVE DISORDER AND POSTPARTUM DEPRESSION IN A LACTATING FEMALE
[patent_app_type] => utility
[patent_app_number] => 18/557705
[patent_app_country] => US
[patent_app_date] => 2022-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25790
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -77
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18557705
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/557705 | NEUROACTIVE STEROID FOR USE IN TREATING MAJOR DEPRESSIVE DISORDER AND POSTPARTUM DEPRESSION IN A LACTATING FEMALE | Apr 28, 2022 | Pending |
Array
(
[id] => 17792148
[patent_doc_number] => 20220251239
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => COMBINATION RADIOIMMUNOTHERAPY AND CD47 BLOCKADE IN THE TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 17/725544
[patent_app_country] => US
[patent_app_date] => 2022-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26022
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17725544
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/725544 | COMBINATION RADIOIMMUNOTHERAPY AND CD47 BLOCKADE IN THE TREATMENT OF CANCER | Apr 19, 2022 | Pending |
Array
(
[id] => 17946080
[patent_doc_number] => 20220333097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => RAPID DESIGN, BUILD, TEST, AND LEARN TECHNOLOGIES FOR IDENTIFYING AND USING NON-VIRAL CARRIERS
[patent_app_type] => utility
[patent_app_number] => 17/715784
[patent_app_country] => US
[patent_app_date] => 2022-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22746
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17715784
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/715784 | Rapid design, build, test, and learn technologies for identifying and using non-viral carriers | Apr 6, 2022 | Issued |
Array
(
[id] => 19263766
[patent_doc_number] => 20240207463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-27
[patent_title] => RADIOACTIVE COMPLEX OF ANTI-EGFR ANTIBODY, AND RADIOPHARMACEUTICAL
[patent_app_type] => utility
[patent_app_number] => 18/553443
[patent_app_country] => US
[patent_app_date] => 2022-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21384
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18553443
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/553443 | RADIOACTIVE COMPLEX OF ANTI-EGFR ANTIBODY, AND RADIOPHARMACEUTICAL | Mar 30, 2022 | Pending |
Array
(
[id] => 20401313
[patent_doc_number] => 12491273
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-09
[patent_title] => Radiopharmaceuticals at different activity reference times
[patent_app_type] => utility
[patent_app_number] => 18/286675
[patent_app_country] => US
[patent_app_date] => 2022-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 2753
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 348
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18286675
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/286675 | Radiopharmaceuticals at different activity reference times | Mar 16, 2022 | Issued |
Array
(
[id] => 17640616
[patent_doc_number] => 20220168354
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => Compositions Comprising Milk Fat Globules
[patent_app_type] => utility
[patent_app_number] => 17/672998
[patent_app_country] => US
[patent_app_date] => 2022-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9657
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17672998
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/672998 | Compositions Comprising Milk Fat Globules | Feb 15, 2022 | Abandoned |
Array
(
[id] => 19447432
[patent_doc_number] => 20240307562
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-19
[patent_title] => ANTI-oxMIF RADIOIMMUNOCONJUGATE
[patent_app_type] => utility
[patent_app_number] => 18/275179
[patent_app_country] => US
[patent_app_date] => 2022-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28756
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18275179
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/275179 | ANTI-oxMIF RADIOIMMUNOCONJUGATE | Feb 1, 2022 | Pending |
Array
(
[id] => 19049421
[patent_doc_number] => 20240091390
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => IMPROVED CHOLECYSTOKININ-2 RECEPTOR (CCK2R) TARGETING FOR DIAGNOSIS AND THERAPY
[patent_app_type] => utility
[patent_app_number] => 18/263797
[patent_app_country] => US
[patent_app_date] => 2022-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11758
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -41
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18263797
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/263797 | IMPROVED CHOLECYSTOKININ-2 RECEPTOR (CCK2R) TARGETING FOR DIAGNOSIS AND THERAPY | Feb 1, 2022 | Pending |
Array
(
[id] => 19431049
[patent_doc_number] => 20240299547
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-12
[patent_title] => CAVITATION AGENT
[patent_app_type] => utility
[patent_app_number] => 18/272110
[patent_app_country] => US
[patent_app_date] => 2022-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16783
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18272110
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/272110 | CAVITATION AGENT | Jan 30, 2022 | Pending |